NeuropaceNPCE
13F holders, Q1 2024 (March 31)54holders
3famous investors
$13.20avg. 13F price*
At the end of Q1 2024, 54 institutions reported holding Neuropace Inc. (NPCE) in their 13F filings. The largest holders were Orbimed Advisors LLC ($52.9M), Morgan Stanley ($32.8M) and Soleus Capital Management, L.P. ($32.1M). 3 famous investors held it, including Israel Englander (0.0% of Millennium Management's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Neuropace Inc.
- CUSIP
- 641288105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 18 | $5.4M |
| Exits | 5 | $535K |
Ownership 54 holders
| Orbimed Advisors LLC | 0.97% | No change | 4,003,967 | $52.9M |
| Morgan Stanley | 0.00% | Add +0.9% | 2,483,983 | $32.8M |
| Soleus Capital Management, L.P. | 2.82% | No change | 2,433,168 | $32.1M |
| Nantahala Capital Management, LLC | 1.01% | Reduce -33.7% | 778,260 | $10.3M |
| Kent Lake Capital LLC | 3.71% | Reduce -4.1% | 643,629 | $8.5M |
| Millennium Management | 0.01% | Add +251.3% | 605,713 | $8.0M |
| Vanguard Group Inc. | 0.00% | Add +18.3% | 488,618 | $6.4M |
| FMR LLC | 0.00% | Reduce -35.3% | 302,803 | $4.0M |
| Susquehanna International Group, LLP | 0.00% | Add +381.9% | 203,776 | $2.7M |
| Goldman Sachs Group Inc. | 0.00% | New | 139,843 | $1.8M |
| Renaissance Technologies | 0.00% | Add +10.8% | 119,971 | $1.6M |
| Geode Capital Management, LLC | 0.00% | Add +0.8% | 116,960 | $1.5M |
| Citigroup Inc. | 0.00% | Add +116.1% | 75,688 | $999K |
| Informed Momentum Co LLC | 0.16% | Add +14.3% | 75,625 | $998K |
| BlackRock Inc. | 0.00% | Reduce -14.3% | 74,154 | $979K |
| Jane Street Group, LLC | 0.00% | Add +95.6% | 72,013 | $951K |
| Marshall Wace, LLP | 0.00% | Add +311.8% | 58,358 | $770K |
| Cubist Systematic Strategies, LLC | 0.01% | Add +344.4% | 50,725 | $670K |
| Acadian Asset Management LLC | 0.00% | New | 47,215 | $621K |
| Qube Research & Technologies Ltd | 0.00% | Add +72.6% | 45,218 | $597K |
| Man Group plc | 0.00% | Add +96.6% | 37,942 | $501K |
| State Street Corp. | 0.00% | Add +11.7% | 37,251 | $492K |
| Bridgeway Capital Management, LLC | 0.01% | Reduce -2.1% | 33,200 | $438K |
| JPMorgan Chase & Co. | 0.00% | Add +182.7% | 32,115 | $424K |
| HRT Financial LP | 0.00% | New | 31,921 | $421K |
| Northern Trust Corp. | 0.00% | Reduce -15.5% | 29,594 | $391K |
| Marathon Trading Investment Management LLC | 0.15% | New | 28,000 | $370K |
| Balyasny Asset Management L.P. | 0.00% | Reduce -0.8% | 26,950 | $356K |
| Jump Financial, LLC | 0.01% | New | 25,538 | $337K |
| Petrus Trust Company, LTA | 0.03% | New | 23,904 | $316K |
| Laurion Capital Management LP | 0.01% | No change | 20,699 | $273K |
| Walleye Capital LLC | 0.00% | Add +37.6% | 19,698 | $260K |
| ExodusPoint Capital Management, LP | 0.00% | Reduce -1.8% | 19,431 | $256K |
| Bantamac Capital, LLC | 0.14% | New | 18,499 | $244K |
| XTX Topco Ltd | 0.03% | New | 15,412 | $203K |
| Brevan Howard Capital Management LP | 0.02% | New | 15,034 | $198K |
| Schonfeld Strategic Advisors LLC | 0.00% | New | 14,426 | $190K |
| Barclays PLC | 0.00% | Reduce -0.7% | 13,870 | $183K |
| Bank of America Corp. | 0.00% | Reduce -57.0% | 13,706 | $181K |
| Squarepoint Ops LLC | 0.00% | New | 13,316 | $176K |
| Hillsdale Investment Management Inc. | 0.01% | New | 11,750 | $155K |
| Jefferies Financial Group Inc. | 0.00% | New | 10,900 | $144K |
| Y-Intercept (Hong Kong) Ltd | 0.01% | New | 10,491 | $138K |
| Point72 Asia (Singapore) Pte. Ltd. | 0.04% | Add +3938.5% | 10,379 | $137K |
| Financial Advocates Investment Management | 0.01% | No change | 10,000 | $132K |
| Citadel Advisors | 0.00% | Reduce -66.1% | 8,150 | $108K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +1393.3% | 3,763 | $50K |
| Lazard Asset Management LLC | 0.00% | Reduce -9.9% | 3,541 | $46K |
| Wells Fargo & Company | 0.00% | Add +2470.4% | 2,082 | $27K |
| UBS Group AG | 0.00% | New | 1,700 | $22K |
| EntryPoint Capital, LLC | 0.02% | New | 1,632 | $22K |
| Federated Hermes, Inc. | 0.00% | Add +94.8% | 226 | $3K |
| Cwm, LLC | 0.00% | New | 166 | $2K |
| Macquarie Group Ltd. | 0.00% | New | 1,198 | $16 |
"% of holder's portfolio" is NPCE's weight in each manager's 13F, not the share of Neuropace Inc. the manager owns.